Last reviewed · How we verify

Pioglitazone and metformin and insulin

Takeda · FDA-approved active Small molecule Quality 2/100

Pioglitazone and metformin and insulin is a Small molecule drug developed by Takeda. It is currently FDA-approved. Also known as: ACTOS®.

At a glance

Generic namePioglitazone and metformin and insulin
Also known asACTOS®
SponsorTakeda
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pioglitazone and metformin and insulin

What is Pioglitazone and metformin and insulin?

Pioglitazone and metformin and insulin is a Small molecule drug developed by Takeda.

Who makes Pioglitazone and metformin and insulin?

Pioglitazone and metformin and insulin is developed and marketed by Takeda (see full Takeda pipeline at /company/takeda).

Is Pioglitazone and metformin and insulin also known as anything else?

Pioglitazone and metformin and insulin is also known as ACTOS®.

What development phase is Pioglitazone and metformin and insulin in?

Pioglitazone and metformin and insulin is FDA-approved (marketed).

Related